A metabolomics investigation of a hyper- and hypo-virulent phenotype of Beijing lineage M. tuberculosis

Metabolomics

Volumn 8, Issue 6, 2012, Pages 1194-1203

  Meissner Roloff, Reinart J ^a   Koekemoer, Gerhard ^a   Warren, Robert M ^b   Loots, Du Toit ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Beijing M. tuberculosis; Hyper and hypo virulence; Metabolomics

Indexed keywords

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CELL FUNCTION; CONTROLLED STUDY; ENERGY YIELD; GAS CHROMATOGRAPHY; METABOLOME; METABOLOMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; STRAIN DIFFERENCE; TIME OF FLIGHT MASS SPECTROMETRY;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84868379186     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-012-0424-6     Document Type: Article

References (55)

1. Acharya, P. V., & Goldman, D. S. (1970). Chemical composition of the cell wall of the H37Ra strain of Mycobacterium tuberculosis. Journal of Bacteriology, 102(3), 733-739.
2. Aguilar, D., Hanekom, M., Mata, D., Gey van Pittius, N. C., van Helden, P. D., Warren, R., et al. (2009). Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission. Tuberculosis, 90(5), 319-325.
3. Bifani, P. J., Mathema, B., Kurepina, N. E., & Kreiswirth, B. N. (2002). Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends in Microbiology, 10, 45-52.
4. Brennan, P. J. (2003). Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis, 83, 91-97.
5. Brennan, P. J., & Nikaido, H. (1995). The envelope of mycobacteria. Annual Review of Biochemistry, 64, 29-63.
6. Bryk, R., Lima, C. D., Erdjument-Bromage, H., Tempst, P., & Nathan, C. (2002). Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science, 295, 1073-1077.
7. Buchrieser, C., & Cole, S. T. (2009). From functional genomics to systems (micro)biology. Current Opinions in Microbiology, 12(5), 528-530.
8. Chatterjee, D. (1997). The mycobacterial cell wall: Structure, biosynthesis and sites of drug action. Current Opinion in Chemical Biology, 1(4), 579-588.
9. Chatterjee, D., & Khoo, K. H. (1998). Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects. Glycobiology, 8(2), 113-120.
10. Chen, I. W., & Charalampous, C. F. (1966). Biochemical studies on inositol. IX. D-Inositol 1-phosphate as intermediate in the biosynthesis of inositol from glucose 6-phosphate, and characteristics of two reactions in this biosynthesis. Journal of Biological Chemistry, 241(10), 2194-2199.
11. Coates, A., Hu, Y., Bax, R., & Page, C. (2002). The future challenges facing the development of new antimicrobial drugs. Nature Reviews Drug Discovery, 1(11), 895-910.
12. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Chucher, C., Harris, D., et al. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Natutre, 393, 537-544.
13. De Carvalho, L. P. S., Fischer, S. M., Marrero, J., Nathan, C., Ehrt, S., & Rhee, K. Y. (2010). Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Cell, 17, 1122-1131.
14. de Souza, G. A., Fortuin, S., Aguilar, D., Pando, R. H., McEvoy, C. R., van Helden, P. D., et al. (2010). Using a label-free proteomics method to identify differentially abundant proteins in closely related hypo- and hypervirulent clinical Mycobacterium tuberculosis Beijing isolates. Molecular and Cellular Proteomics, 9(11), 2414-2423.
15. Deb, C., Daniel, J., Sirakova, T. D., Abomoelak, B., Dubey, V. S., & Kolattukudy, P. E. (2007). A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. Journal of Biological Chemistry, 281(7), 3866-3875.
16. Dormans, J., Burger, M., Aguilar, D., Hernandez-Pando, R., Kremer, K., Roholl, P., et al. (2004). Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clinical and Experimental Immunology, 137, 460-468.
17. Fiehn, O., Kopka, J., Trethewey, R. N., & Willmitzer, L. (2000). Identification of uncommon plant metabolites based on calculation of elemental compositions using gas chromatography and quadrupole mass spectrometry. Analytical Chemistry, 72, 3573-3580.
18. Field, A. (2005). Non parametric tests. In A. Field (Ed.), Discovering statistics using SPSS (pp. 532-533). London: SAGE publications.
19. Filliol, I., Driscoll, J. R., van Soolingen, D., Kreiswirth, B. N., Kremer, K., Valetudie, G., et al. (2003). Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. Journal of Clinical Microbiology, 41, 1963-1970.
20. Glynn, J. R., Whiteley, J., Bifani, P. J., Kremer, K., & van Soolingen, D. (2002). Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: A systematic review. Emerging Infectious Diseases, 8(8), 843-849.
21. Gordon, S. V., Brosch, R., Billault, A., Garnier, T., Eiglmeier, K., & Cole, S. T. (1999). Identification of variable regions in the genome of tubercle bacilli using bacterial artificial chromosome arrays. Molecular Microbiology, 32(3), 643-655.
22. Kamio, Y., Itoh, Y., Terawaki, Y., & Kusano, T. (1981). Cadaverine is covalently linked to peptidoglycan in Selenomonas ruminantium. Journal of Bacteriology, 145(1), 122-128.
23. Kanani, H., Chrysanthopoulos, P. K., & Klapa, M. I. (2008). Standardizing GC-MS metabolomics. Journal of Chromatography, 871, 191-201.
24. Karboul, A., Mazza, A., Gey Van Pittius, N. C., Ho, J. L., Brousseau, R., & Mardassi, H. (2008). Frequent homologous recombination events in Mycobacterium tuberculosis PE/PPE multigene families: Potential role in antigenic variability. Journal of Bacteriology, 190(23), 7838-7846.
25. Kendall, S. L., Withers, M., Soffair, C. N., Moreland, N. J., Gurcha, S., Sidders, B., et al. (2007). A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis. Molecular Microbiology, 65(3), 684-699.
26. Kremer, K., van-der-Werf, M. J., Au, B. K., Anh, D. D., Kam, K. M., van-Doorn, H. R., et al. (2009). Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains. Emerging Infectious Diseases, 15(2), 335-339.
27. Lopez, B., Aguilar, D., Orozco, H., Burger, M., Espitia, C., Ritacco, V., et al. (2003). A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clinical and Experimental Immunology, 133, 30-37.
28. Målen, H., De Souza, G. A., Pathak, S., Søfteland, T., & Wiker, H. G. (2011). Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains. BMC Microbiology, 24(11), 18.
29. Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., et al. (2001). Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Procedings of the National Academy of Sciences USA, 98, 5752-5757.
30. Neely, M. N., & Olson, E. R. (1996). Kinetics of expression of the Escherichia coli cad operon as a function of pH and lysine. Journal of Bacteriology, 178(18), 5522-5528.
31. Newton, G. L., Av-Gay, Y., & Fahey, R. C. (2000). A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase. Biochemistry, 39(35), 10739-10746.
32. O'Barr, T. P., & Everett, K. A. (1970). Effect of l-homoserine of growth of Mycobacterium tuberculosis. Infection and Immunity, 3(2), 328-332.
33. Paley, S. M., & Karp, P. D. (2006). The pathway tools cellular overview diagram and omics viewer. Nucleic Acids Research, 34(13), 3771-3778.
34. Parish, T., Liu, J., Nikaido, H., & Stoker, N. G. (1997). A Mycobacterium smegmatis mutant with a defective inositol monophosphate phosphatase gene homolog has altered cell envelope permeability. Journal of Bacteriology, 179(24), 7827-7833.
35. Parish, T., Smith, D. A., Kendall, S., Casali, N., Bancroft, G. J., & Stoker, N. G. (2003). Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infection and Immunity, 71, 1134-1140.
36. Pheiffer, C., Betts, J. C., Flynn, H. R., Lukey, P. T., & van Helden, P. (2005). Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv. Microbiology, 151(4), 1139-1150.
37. Qureshi, N., Sathyamoorthy, N., & Takayama, K. (1984). Biosynthesis of C30 to C56 fatty acids by an extract of Mycobacterium tuberculosis H37Ra. Journal of Bacteriology, 157(1), 46-52.
38. Rad, M. E., Bifani, P., Martin, C., Kremer, K., Samper, S., Rauzier, J., et al. (2003). Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerging Infectious Diseases, 9, 838-845.
39. Ramakrishnan, T., Murthy, P. S., & Gopinathan, K. P. (1972). Intermediary metabolism of mycobacteria. Bacteriology Review, 36(1), 65-108.
40. Ramos, J. L., Martínez-Bueno, M., Molina-Henares, A. J., Terán, W., Watanabe, K., Zhang, X., et al. (2005). The TetR family of transcriptional repressors. Microbiology and Molecular Biology Reviews, 69(2), 326-356.
41. Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., et al. (2004). A glyco-lipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature, 431, 84-87.
42. Reed, M. B., Gagneux, S., DeRiemer, K., Small, P. M., & Barry, C. E, I. I. I. (2007). The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. Journal of Bacteriology, 189(7), 2583-2589.
43. Reitzer, L. (2003). Nitrogen assimilation and global regulation in Escherichia coli. Annual Review of Microbiology, 57, 155-176.
44. Rocha-Ramírez, L. M., Estrada-García, I., López-Marín, L. M., Segura-Salinas, E., Méndez-Aragón, P., van Soolingen, D., et al. (2008). Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis, 88(3), 212-220.
45. Samartzidou, H., & Delcour, A. H. (1998). E. coli PhoE porin has an opposite voltage-dependence to the homologous OmpF. EMBO Journal, 17(1), 93-100.
46. Sareen, D., Newton, G. L., Fahey, R. C., & Buchmeier, N. A. (2003). Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman. Journal of Bacteriology, 185(22), 6736-6740.
47. Shi, L., Sohaskey, C. D., Pfeiffer, C., Datta, P., Parks, M., McFadden, J., et al. (2010). Carbon flux rerouting during Mycobacterium tuberculosis growth arrest. Molecular Microbiology, 78(5), 1199-1215.
48. Tsenova, L., Ellison, E., Harbacheuski, R., Moreira, A. L., Kurepina, N., Reed, M. B., et al. (2005). Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. Journal of Infectious Diseases, 192(1), 98-106.
49. Umbarger, H. E. (1978). Amino acid biosynthesis and its regulation. Annual Review Biochemistry., 47, 532-606.
50. van Soolingen, D., Qian, L., deHaas, P. E., Douglas, J. T., Traore, H., Portaels, F., et al. (1995). Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. Journal of Clinical Microbiology, 33, 3234-3238.
51. Vercellone, A., Nigou, J., & Puzo, G. (1998). Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis. Frontiers Bioscience, 3, 149-163.
52. Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., et al. (2003). Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. Journal of Experimental Medicine, 198, 705-713.
53. Warren, R., Richardson, M., Sampson, S., Hauman, J. H., Beyers, N., Donald, P. R., et al. (1996). Genotyping of Mycobacterium tuberculosis with additional markers enhances accuracy in epidemiological studies. Journal of Clinical Microbiology, 34(9), 2219-2224.
54. Zheng, H., Lu, L., Wang, B., Pu, S., Zhang, X., Zhu, G., et al. (2008). Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS ONE, 3(6), e2375.
55. Ziebart, K. T., Dixon, S. M., Avila, B., El-Badri, M. H., Guggenheim, K. G., Kurth, M. J., et al. (2010). Targeting multiple chorismate-utilizing enzymes with a single inhibitor: Validation of a three-stage design. Journal of Medicinal Chemistry, 53(9), 3718-3729.